CD274 and non-small cell lung carcinoma: For instance, in non-small cell lung cancer cell lines, the use of AZA has been shown to increase the expression of the inhibitory ligand PD-L1, resulting in the consistent downregulation of immune genes and PD-L1 expression in specific subsets of primary tumors.